In this review:
Faecal transplantation with or without a novel UC diet
Ustekinumab vs adalimumab for moderate-to-severe CD
Anti-SARS-CoV2 antibody responses attenuated by infliximab
Sonographic inflammation predicts clinical complications in CD
Surgical closure of CD perianal fistulas after anti-TNF induction
Disease clearance as therapeutic target in UC
Lyophilised oral faecal transplantation for UC
Ultra-processed food intake and risk of IBD
Non-invasive assessment of postoperative disease recurrence in CD
Immunomodulator withdrawal from anti-TNF combination therapy
Please login below to download this issue (PDF)